Trials / NCT01999049
Observational Study of the Argus® II Retinal Prosthesis System
Status unknown Observational Natural history / observational
- Sponsor
- University Health Network, Toronto
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 25 Years to no upper limit
- Enrollment
- 10 participants
- Started
- 2014-04
- Main results expected
- 2016-01
- Results posted
- Not yet
- Record last updated
- 2015-04-24
What the study is testing
The Argus II Retinal Implant is a revolutionary new device, which offers vision to patients who are blind from retinal degeneration - retinitis pigmentosa. These patients have no alternatives. Patients typically can achieve ambulatory vision.
Where it runs
Canada (1)
- UHN Toronto Western Hospital 6E-438, Toronto, Ontario (recruiting now)